Regency Capital Management Inc.\De Morphic Holding, Inc. Transaction History

Regency Capital Management Inc.\De

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$36.25 - $52.02 $0 - $0	0 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$43.27 - $65.72 $199,042 - $302,312	-4,600 Closed	0 $0
Q2 2021 Jul 07, 2021	SELL	$45.13 - $64.99 $4,513 - $6,498	-100 Reduced 2.13%	4,600 $264,000
Q1 2021 May 25, 2021	BUY	$29.77 - $84.85 $139,919 - $398,795	4,700 New	4,700 $297,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Regency Capital Management Inc.\De, based on Form 13F filings with the SEC.

Stay updated on Regency Capital Management Inc.\De with notifications on news.